CompaniesAmira Medical

Amira Medical

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

2

As Collaborator

3

Total Enrollment

466

By Phase

NA: 2PHASE4: 1

By Status

RECRUITING: 2COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
NCT00796302
NCT05502198
NCT05477277
Hover over trial bars to see details

Recent Trials

NCT05477277Collaborator
Adverse Outcomes and Mortality in Liver Transplant
NARecruiting
100 participants
Started: Nov 2, 2022 · Completed: Jul 1, 2027
NCT05184283Collaborator
Utilization of MAsS in Patients Undergoing LT for HCC
N/ATerminated
11 participants
Started: Jun 16, 2022 · Completed: Nov 29, 2023
NCT05122143Lead Sponsor
Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers
NACompleted
37 participants
Started: Nov 10, 2021 · Completed: Apr 4, 2022
NCT05502198Collaborator
Relevance of Sarcopenia in Advanced Liver Disease
N/ARecruiting
150 participants
Started: Feb 1, 2021 · Completed: Jun 30, 2030
NCT00796302Lead Sponsor
Treatment of Severe Childhood Aggression (The TOSCA Study)
PHASE4Completed
168 participants
Started: Aug 31, 2008 · Completed: Nov 30, 2012
Related Companies
Roche
acquired